<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1A588798-5C6D-461F-9268-30045D7B6854"><gtr:id>1A588798-5C6D-461F-9268-30045D7B6854</gtr:id><gtr:firstName>Michel</gtr:firstName><gtr:surname>Goedert</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105184291"><gtr:id>EF2AED19-3B13-48F6-A841-E4E491C165F3</gtr:id><gtr:title>Molecular mechanisms of neurodegeneration</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105184291</gtr:grantReference><gtr:abstractText>Alzheimer's disease and Parkinson's disease are the most common neurodegenerative diseases, affecting approximately 30 million people worldwide. Existing therapies are at best symptomatic. The symptoms of Alzheimer's disease (a dementing disorder) and Parkinson's disease (a movement disorder) result from the dysfunction and degeneration of specific types of nerve cells in particular brain regions. These nerve cells are characterized by the presence of abnormal filamentous deposits. Similar deposits also characterize several other neurodegenerative diseases, such as progressive supranuclear palsy, corticobasal degeneration, Pick's disease and other frontotemporal dementias, dementia with Lewy bodies and multiple system atrophy. Collectively, they account for the vast majority of cases of neurodegenerative disease in man. Our previous work was instrumental in establishing that the filamentous deposits characteristic of these diseases are made of either the microtubule-associated protein tau or the protein alpha-synuclein. It is now widely believed that their formation causes nerve cell degeneration. Our current work is aimed at understanding the mechanisms by which the normally soluble tau and alpha-synuclein proteins assemble into abnormal filaments, propagate through the brain and cause neurodegeneration. To this effect, we are developing experimental models of tau and alpha-synuclein deposition. In due course, this work may lead to the development of mechanism-based therapies for the tauopathies and the alpha-synucleinopathies.</gtr:abstractText><gtr:technicalSummary>Considerable progress has been made in characterizing the molecular neuropathology of dementias and movement disorders, including Alzheimer?s and Parkinson?s diseases. Most cases of disease associated with pathological filament formation are now accounted for by either tau or alpha-synuclein deposits. The discoveries of mutations in MAPT, the tau gene, in inherited forms of frontotemporal dementia, and SNCA, the alpha-synuclein gene, in inherited forms of Parkinson?s disease, have established that the pathways leading from soluble to insoluble, filamentous proteins are central to the aetiology and pathogenesis of these familial cases of disease. The same is probably true of the much more common cases of sporadic disease. A detailed understanding of the mechanisms underlying the assembly of tau and alpha-synuclein into abnormal filaments could provide novel therapeutic options. We are in the process of investigating the relevance of individual phosphorylation sites in tau by producing lines of transgenic mice with mutations in these sites. This work is based on the hypothesis that the abnormal hyperphosphorylation of tau contributes directly to neurodegeneration. We are also studying the importance of tau aggregation for the neurodegenerative process by producing mouse lines transgenic for human mutant tau that is unable to aggregate. In 2009, we showed that experimental tauopathy can be transmitted and that it spreads between adjacent brain regions in a tau-dependent manner. We are using cell assays to define the mechanisms of tau aggregate uptake and seeding. Like aggregated tau, aggregated alpha-synuclein also behaves in a ?prion-like? manner. We are using transgenic mice and cell models, in conjunction with brain extracts from patients with Parkinson?s disease and multiple system atrophy, to define spreading pathways and molecular conformers. We are also using the cell models to define mechanisms of aggregate uptake and seeding. Current evidence indicates that in human tauopathies and synucleinopathies, nucleation-dependent aggregation may happen in a localised fashion, followed by seed-dependent propagation. In 2013, we showed that different molecular conformers of aggregated tau (or strains) might account for different human tauopathies. The definition of a strain of aggregated tau needs to be structural. In recent collaborative work with the group of S. Scheres at the LMB, we have determined the high-resolution structures of tau filaments from Alzheimer?s disease brain by cryo-electron microscopy (cryo-EM). We showed that paired helical and straight filaments are ultrastructural polymorphs that are made of a common protofilament. This work has shown that cryo-EM allows atomic characterization of amyloid filaments from patient-derived material, and paves the way to study a range of neurodegenerative diseases.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1987-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>16269132</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>145892</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>JPND</gtr:description><gtr:fundingOrg>JPND Research</gtr:fundingOrg><gtr:fundingRef>MC_EX_MR/N027892/1</gtr:fundingRef><gtr:id>F59F8A0D-8E93-4F11-B766-DE7970B7F699</gtr:id><gtr:outcomeId>56d062207c0549.29604324</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>626557</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU-FP7 grant</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9B2C1087-FCCE-40A1-BA18-06F15E017602</gtr:id><gtr:outcomeId>20EF0D1D1E30</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25072</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Network Emergency Fellowship (SZ)</gtr:description><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>19C669E7-170A-4819-9383-5531123F3CAD</gtr:id><gtr:outcomeId>A4681BE00500</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115531</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Fellowship (SZ)</gtr:description><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>23B4E931-6A85-4994-A309-1B91AF51022B</gtr:id><gtr:outcomeId>3FD106D661C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Medical Research Foundation Whitaker Fund</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2A2F7DDE-9BF9-417A-B7A8-8D624001FC04</gtr:id><gtr:outcomeId>56d05f304e1fb3.62159713</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>335948</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Eli Lilly Research Collaboration Agreement</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>B284B74D-CE05-42FB-A0EA-460B19AA0151</gtr:id><gtr:outcomeId>56d0604026de92.27402507</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4340</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARUK Camb Network Pump Priming Grant - Byron Andrews</gtr:description><gtr:fundingOrg>Babraham Institute</gtr:fundingOrg><gtr:id>DE93B972-2D66-440C-9CD1-BFA15D1E26D5</gtr:id><gtr:outcomeId>56d06180ed3016.77764945</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62694</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Cambridge Clinical School Studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:fundingRef>NA</gtr:fundingRef><gtr:id>B241A0E4-7B21-4D43-B6C6-E83AE412A401</gtr:id><gtr:outcomeId>56d05fc19d3ed6.44304147</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Foundation of Research on Alzheimer Disease Prize Fund</gtr:description><gtr:fundingOrg>Alzheimer's Research Foundation</gtr:fundingOrg><gtr:id>E5512DA9-1967-417C-900A-25B7955563FB</gtr:id><gtr:outcomeId>56d060febe10a3.37387114</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34253</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant (SZ)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>B4829EF4-8878-41F8-AFCA-7D52435DA911</gtr:id><gtr:outcomeId>P1koueJotbb0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>146018</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Material use licence and collaboration agreement</gtr:description><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>D5316067-0891-4E12-B67E-DB7CB1D2D74A</gtr:id><gtr:outcomeId>53754BB822C0</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>31064</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Prize</gtr:description><gtr:fundingOrg>MetLife</gtr:fundingOrg><gtr:id>0A87B1A1-E99E-4918-890A-2DBE4DB3876D</gtr:id><gtr:outcomeId>sbz2ZxNKfbT</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C9B024A6-B3F5-49AD-B198-BA8342680EC3</gtr:id><gtr:title>Why has therapy development for dementia failed in the last two decades?</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4887f7cb28dbdf7675cc19c781076e6d"><gtr:id>4887f7cb28dbdf7675cc19c781076e6d</gtr:id><gtr:otherNames>Gauthier S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>56cf14ee5b9888.36682047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>100CE290-9B78-45A0-A405-E6188E54BB39</gtr:id><gtr:title>Botulinum protease-cleaved SNARE fragments induce cytotoxicity in neuroblastoma cells.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1d01316e35afbae3f445e49a4e2febb"><gtr:id>c1d01316e35afbae3f445e49a4e2febb</gtr:id><gtr:otherNames>Arsenault J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>56cf151c57e0b4.38091228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4491272-77C9-43F4-B05E-C95BE7051591</gtr:id><gtr:title>Prions and the like</gtr:title><gtr:parentPublicationTitle>Brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>ZxHsJNtbPYP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404A8A1C-C605-481E-917B-AD3CF2A00E3F</gtr:id><gtr:title>The Prion-Like Behavior of Assembled Tau in Transgenic Mice.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>58b5a50811bd77.56552440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>882942EF-8A4D-490D-95B1-5B4FD730E003</gtr:id><gtr:title>Frontotemporal dementia: implications for understanding Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_13947_27_22355793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FD0FC91-5256-46B3-92F3-51D046A6B85D</gtr:id><gtr:title>In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b022d910d33422980220c19f32aa274b"><gtr:id>b022d910d33422980220c19f32aa274b</gtr:id><gtr:otherNames>Ye L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>4E166617FF7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2204CBD0-3992-4D4D-9C24-89DF2CDC25CD</gtr:id><gtr:title>Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ea3e129b0f6e620740ca66a5e93d5ff"><gtr:id>2ea3e129b0f6e620740ca66a5e93d5ff</gtr:id><gtr:otherNames>Ghetti B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56cf1181ad3da2.62172499</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95F23DED-196B-4103-A495-487E6116E4D8</gtr:id><gtr:title>Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5127c337c4d35c97966a996e685b8462"><gtr:id>5127c337c4d35c97966a996e685b8462</gtr:id><gtr:otherNames>McEwan WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a2fd887e78c05.01229645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E6355AA-7DD8-4582-AA44-7142E6E17722</gtr:id><gtr:title>The novel Tau mutation G335S: clinical, neuropathological and molecular characterization.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c57fe98a7077ec4da99908912e27085"><gtr:id>3c57fe98a7077ec4da99908912e27085</gtr:id><gtr:otherNames>Spina S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>E9D18AAC0FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2F08ECD-1280-4562-852B-95A61E8A6266</gtr:id><gtr:title>A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63d933ac4d7cc10c11a493876994bb7d"><gtr:id>63d933ac4d7cc10c11a493876994bb7d</gtr:id><gtr:otherNames>Zibaee S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>63BA4C97CAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51788D72-5B71-40CA-8789-6961B6B44BDC</gtr:id><gtr:title>Small molecule inhibitors of alpha-synuclein filament assembly.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78f5fd1104e1bb4ed54f8e7d150e98d4"><gtr:id>78f5fd1104e1bb4ed54f8e7d150e98d4</gtr:id><gtr:otherNames>Masuda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>ABFCD1C1CD3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C395E9-1976-4739-A338-AC0833C8C6D5</gtr:id><gtr:title>Parkinson's disease - the story of an eponym.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>5a82de754c4da5.02537389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4E7A575-6240-409A-B764-4CDF986D030A</gtr:id><gtr:title>Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/426613ef10e3976e59b014195faab972"><gtr:id>426613ef10e3976e59b014195faab972</gtr:id><gtr:otherNames>Yamashita M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>E8BEAD5F438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A946AE-D938-4B40-8D3D-3D4BDE30994D</gtr:id><gtr:title>Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568d4c05c5540e8104cf9ff299119e4d"><gtr:id>568d4c05c5540e8104cf9ff299119e4d</gtr:id><gtr:otherNames>Schaeffer V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_13947_27_22874558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8690F7A-DBBC-4374-AD6F-40A6D5D040CD</gtr:id><gtr:title>White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>F7F92831ADC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BAC619E-CADC-4E69-BCE6-0E86CE26AA41</gtr:id><gtr:title>Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9a459db5eb95e716cced7a352cee42f"><gtr:id>f9a459db5eb95e716cced7a352cee42f</gtr:id><gtr:otherNames>Spillantini MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_13947_17_16914875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5E68236-DC68-4245-9CDA-049796DC2254</gtr:id><gtr:title>Cell-mediated neuroprotection in a mouse model of human tauopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906b4a3a76f781fdc13be9940bd5b2a6"><gtr:id>906b4a3a76f781fdc13be9940bd5b2a6</gtr:id><gtr:otherNames>Hampton DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pv7cLh5zjhe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC52BB7-0495-4126-9166-337BCE6E7820</gtr:id><gtr:title>Conformation determines the seeding potencies of native and recombinant Tau aggregates.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17b63d4098cddfd791643c58a7147874"><gtr:id>17b63d4098cddfd791643c58a7147874</gtr:id><gtr:otherNames>Falcon B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56cf1057e83604.72088809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>252ADB57-9548-4443-9877-3829BFD60F5B</gtr:id><gtr:title>Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d53dc411eaa8076bf0f210f67a3997f"><gtr:id>3d53dc411eaa8076bf0f210f67a3997f</gtr:id><gtr:otherNames>Delobel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>D2E1DFF4E11</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1E403F2-9005-4574-90B5-4750E26D9C1D</gtr:id><gtr:title>Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae9390d3a35dd8abe7fe3ee2dce1ad00"><gtr:id>ae9390d3a35dd8abe7fe3ee2dce1ad00</gtr:id><gtr:otherNames>Ghetti B, Wszolek ZW, Boeve BF, Spina S, Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>aNkEy2hfZTm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DD5FFF7-AF1C-43EC-B44C-2D4786DA1392</gtr:id><gtr:title>Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4902c4662ada16cd3fac828563aaf93"><gtr:id>b4902c4662ada16cd3fac828563aaf93</gtr:id><gtr:otherNames>Sch?n C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13947_27_23300938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14EB9B7F-691C-4BDB-95EB-62682535328F</gtr:id><gtr:title>NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A?, tau, and a-synuclein.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56cf101db2e1a8.10198683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E0FA8D1-799E-4678-985A-EB68B92AB631</gtr:id><gtr:title>Human beta-synuclein rendered fibrillogenic by designed mutations.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63d933ac4d7cc10c11a493876994bb7d"><gtr:id>63d933ac4d7cc10c11a493876994bb7d</gtr:id><gtr:otherNames>Zibaee S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FHfgVaRsbYF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69A0B129-57B7-4C0F-8E06-8C8B47FB3E5B</gtr:id><gtr:title>The value of incomplete mouse models of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c27728169a4a1f82cb2901fd960dc44"><gtr:id>0c27728169a4a1f82cb2901fd960dc44</gtr:id><gtr:otherNames>Radde R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>pm_13947_17_18270700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0423F21-A8CB-4920-860B-B7DEC4B87556</gtr:id><gtr:title>Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d53dc411eaa8076bf0f210f67a3997f"><gtr:id>3d53dc411eaa8076bf0f210f67a3997f</gtr:id><gtr:otherNames>Delobel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>F4899FF87B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F3E4519-0914-434E-A212-2D41DF340AD8</gtr:id><gtr:title>Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>56cf12dc424b42.46181166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E16AF354-7910-460F-979F-2A1954B8EC6C</gtr:id><gtr:title>Early behavioural markers of disease in P301S tau transgenic mice.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c340848e587db97ec7bf146300e7fdfa"><gtr:id>c340848e587db97ec7bf146300e7fdfa</gtr:id><gtr:otherNames>Scattoni ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>B9MqBK2sD8a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A44E893-2CB9-4606-8E94-32D9FA3A0073</gtr:id><gtr:title>The involvement of dityrosine crosslinking in a-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7c98cf8970a3e2453f4f51dcaff8307"><gtr:id>c7c98cf8970a3e2453f4f51dcaff8307</gtr:id><gtr:otherNames>Al-Hilaly YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b5a507c0df43.46329880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AC0C454-B974-44B4-9E17-DBF2D51D6D8E</gtr:id><gtr:title>The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8aeb6b28b8c92ecd7ba0d456ecc1522"><gtr:id>d8aeb6b28b8c92ecd7ba0d456ecc1522</gtr:id><gtr:otherNames>Iovino M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_13947_27_24292008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9524308E-E874-4077-B3F8-D48A38E3970D</gtr:id><gtr:title>Interaction of tau protein with the dynactin complex.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68c68014486053b53c7b0a5098c6ad3e"><gtr:id>68c68014486053b53c7b0a5098c6ad3e</gtr:id><gtr:otherNames>Magnani E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>50C6A49922A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB37E29E-A38A-400A-8AD9-5DCEBFEC98E7</gtr:id><gtr:title>Tau: From research to clinical development.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700a2f2a6673232c35e0eed6c35d210b"><gtr:id>700a2f2a6673232c35e0eed6c35d210b</gtr:id><gtr:otherNames>Holtzman DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58b5a50792f0c9.59862190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14264BDA-D0D0-4AE4-9447-6CBA689679D5</gtr:id><gtr:title>Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe71000ea4553c6b9d21e99ad0fbc007"><gtr:id>fe71000ea4553c6b9d21e99ad0fbc007</gtr:id><gtr:otherNames>Gasparini L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>aKRL37yrfKg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>739626BA-BE3D-4B02-965B-FD820D3917D8</gtr:id><gtr:title>Alzheimer: 100 Years and Beyond</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>tx6Bqg8NcfW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97E52751-57ED-4333-B618-472A0745B628</gtr:id><gtr:title>Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f180a15663e642d6e2c71c1a59a300b"><gtr:id>8f180a15663e642d6e2c71c1a59a300b</gtr:id><gtr:otherNames>Yoshida H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>0A7C905B54C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FD753CF-02C4-4F50-89B2-5366B00A6F33</gtr:id><gtr:title>Protein Phosphorylation</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6f2afbf33494f51895e3100186dea06"><gtr:id>d6f2afbf33494f51895e3100186dea06</gtr:id><gtr:otherNames>Goedert Michel</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>ksmogzEWB8Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A908CAD1-8B08-46FA-88E9-459CED5794E6</gtr:id><gtr:title>PART is part of Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13366f5b3cf608c475c69e5e2657b3fd"><gtr:id>13366f5b3cf608c475c69e5e2657b3fd</gtr:id><gtr:otherNames>Duyckaerts C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56cf12901870f5.68557506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62224770-18BF-4161-B216-852F75F69C06</gtr:id><gtr:title>Synucleinopathies: past, present and future.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9a459db5eb95e716cced7a352cee42f"><gtr:id>f9a459db5eb95e716cced7a352cee42f</gtr:id><gtr:otherNames>Spillantini MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56cf1356262ba7.81932265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5223726-4820-466F-8431-076F50C6AF01</gtr:id><gtr:title>Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3cd1ce75fae9df70f2c198e41c5299a"><gtr:id>f3cd1ce75fae9df70f2c198e41c5299a</gtr:id><gtr:otherNames>Hoffmann NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>pm_13947_27_24344647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB43FF67-2A01-4EA3-81EF-1049AAD66C4B</gtr:id><gtr:title>The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9d27ed61bf84f86adc4f95ad8cb89af"><gtr:id>b9d27ed61bf84f86adc4f95ad8cb89af</gtr:id><gtr:otherNames>Brelstaff J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn><gtr:outcomeId>56cf149603afd9.65971437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3BBFB91-9CC7-461D-89E3-F68E65E1AC5D</gtr:id><gtr:title>Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of Parkinson's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc3d325cdc9f5b30d594bd43639eab9f"><gtr:id>cc3d325cdc9f5b30d594bd43639eab9f</gtr:id><gtr:otherNames>Jenner P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1877-7171</gtr:issn><gtr:outcomeId>pm_13947_27_23938306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A48F926-087B-456B-A9AB-D3B2D5BF485D</gtr:id><gtr:title>Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78f5fd1104e1bb4ed54f8e7d150e98d4"><gtr:id>78f5fd1104e1bb4ed54f8e7d150e98d4</gtr:id><gtr:otherNames>Masuda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>0E3BD4E92E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE39372A-9A40-415E-BC78-8BE5C4F209AD</gtr:id><gtr:title>Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene].</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae6a2432f747112164a93095adb3af4"><gtr:id>dae6a2432f747112164a93095adb3af4</gtr:id><gtr:otherNames>Velasco A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>ZzJCJHzuufi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3CB3218-1DAE-4178-B71B-A224F75412DF</gtr:id><gtr:title>Neurodegeneration and the ordered assembly of a-synuclein.</gtr:title><gtr:parentPublicationTitle>Cell and tissue research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9a459db5eb95e716cced7a352cee42f"><gtr:id>f9a459db5eb95e716cced7a352cee42f</gtr:id><gtr:otherNames>Spillantini MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0302-766X</gtr:issn><gtr:outcomeId>5a82dea4a1ae33.27301287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97ECA0A7-5303-49B8-925D-ED399816E7FE</gtr:id><gtr:title>Invited review: Prion-like transmission and spreading of tau pathology.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56cf12fa7f8c33.68499225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F32CF5D-EFEB-4B74-B130-31EFC6AA0761</gtr:id><gtr:title>Evolutionary genomics of plant genes encoding N-terminal-TM-C2 domain proteins and the similar FAM62 genes and synaptotagmin genes of metazoans.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90127821ee20da3aa4f37a2bd499ae83"><gtr:id>90127821ee20da3aa4f37a2bd499ae83</gtr:id><gtr:otherNames>Craxton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>CFD419425C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC224ED0-3F40-41E5-879D-9E1FAA133834</gtr:id><gtr:title>Parkinson's disease: Crystals of a toxic core.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56cf126bee4c30.55584084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F6B026-08EA-4BD0-B406-29AD8E64BCCB</gtr:id><gtr:title>Tau silencing by siRNA in the P301S mouse model of tauopathy.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/278fcc443baec484a682f08515697559"><gtr:id>278fcc443baec484a682f08515697559</gtr:id><gtr:otherNames>Xu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>56cf1469bdf1a3.71435191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F55F933-4481-43D8-8251-5DA82D919C8D</gtr:id><gtr:title>Propagation of Tau aggregates.</gtr:title><gtr:parentPublicationTitle>Molecular brain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-6606</gtr:issn><gtr:outcomeId>5a81afc917a6c8.67831537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E3B84FF-5C5C-4A66-9B3E-1EF0AB8043BD</gtr:id><gtr:title>Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db0dd8311c55f6ae2be27aedcd9d2100"><gtr:id>db0dd8311c55f6ae2be27aedcd9d2100</gtr:id><gtr:otherNames>Ozcelik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13947_27_23667480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B9ACB3-1A30-4DC7-9CC1-05CA8E44B6CF</gtr:id><gtr:title>Encyclopedia of Neuroscience</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>9780080450469</gtr:isbn><gtr:outcomeId>tCcbh8bB2Qz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1BC6946-40AE-4A3F-94D9-626BB69D0D21</gtr:id><gtr:title>Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders - Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>rHJC7BBkorg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>775173FE-92B0-410A-BB0B-4CF19A9893B5</gtr:id><gtr:title>A manual collection of Syt, Esyt, Rph3a, Rph3al, Doc2, and Dblc2 genes from 46 metazoan genomes--an open access resource for neuroscience and evolutionary biology.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90127821ee20da3aa4f37a2bd499ae83"><gtr:id>90127821ee20da3aa4f37a2bd499ae83</gtr:id><gtr:otherNames>Craxton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>eXxYX8XZNkb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACEB56B4-5B3B-4841-9CC2-FF7C9F03DA64</gtr:id><gtr:title>The ordered assembly of tau is the gain-of-toxic function that causes human tauopathies.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58b5a507e35cb8.59391063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>614453D7-8CD5-43DD-B578-5FBA48CFFF3F</gtr:id><gtr:title>Cysteine misincorporation in bacterially expressed human alpha-synuclein.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78f5fd1104e1bb4ed54f8e7d150e98d4"><gtr:id>78f5fd1104e1bb4ed54f8e7d150e98d4</gtr:id><gtr:otherNames>Masuda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>F4A08DCEBD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB900160-B554-4971-B187-366A15342F41</gtr:id><gtr:title>Basic Neurochemistry</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>9780123749475</gtr:isbn><gtr:outcomeId>kJPmLWmkaA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB0437D8-55C4-423D-B35E-6CB55C4132FD</gtr:id><gtr:title>Supramolecular organization of NMDA receptors and the postsynaptic density.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9496d85cf6e325f3ad280db265e83a5"><gtr:id>b9496d85cf6e325f3ad280db265e83a5</gtr:id><gtr:otherNames>Frank RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>5a31d8131e8786.90354659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DE9CA09-BEFA-400E-B9E5-046A21E16E56</gtr:id><gtr:title>The propagation of prion-like protein inclusions in neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>pm_13947_27_20493564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E137D578-CC14-4300-B139-DCB7FC9E4422</gtr:id><gtr:title>Regioselective biolistic targeting in organotypic brain slices using a modified gene gun.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1d01316e35afbae3f445e49a4e2febb"><gtr:id>c1d01316e35afbae3f445e49a4e2febb</gtr:id><gtr:otherNames>Arsenault J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>56cf1314ccec04.71759244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75395EA0-A68E-4838-B29F-19CD0E147B26</gtr:id><gtr:title>Biolistic transfection of neurons in organotypic brain slices.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12b225144eb63c62c465aa38214f0313"><gtr:id>12b225144eb63c62c465aa38214f0313</gtr:id><gtr:otherNames>O'Brien JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_13947_27_23104341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>470C3333-DD79-47F8-AD87-A7861C351216</gtr:id><gtr:title>Propagation of Tau Aggregates and Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Annual review of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0147-006X</gtr:issn><gtr:outcomeId>5a81b332273148.76343046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FC079AD-E8B9-4E65-8703-6D8D02DA5FFF</gtr:id><gtr:title>Alois Alzheimer: his life and times.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>A5E80263E96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58949869-3BAF-47E3-BAE6-82761D935CF2</gtr:id><gtr:title>A century of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_13947_17_17082447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF67C970-152C-4DEF-BCF9-72DBBF826C9F</gtr:id><gtr:title>Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d61b87cc9505a171ece971d872111e67"><gtr:id>d61b87cc9505a171ece971d872111e67</gtr:id><gtr:otherNames>Jackson SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56cf1338679aa8.83934238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0A363DE-7E2A-431C-ABE3-2088A936BF62</gtr:id><gtr:title>Basic Neurochemistry</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53628260954c508114e644515970212e"><gtr:id>53628260954c508114e644515970212e</gtr:id><gtr:otherNames>Goedert M, Spillantini MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>LDLd7j3zBNS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB35B6D6-7EA9-4ABA-8095-A37982C89862</gtr:id><gtr:title>Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef5f7d15714f34044e6374d3dc57fbc5"><gtr:id>ef5f7d15714f34044e6374d3dc57fbc5</gtr:id><gtr:otherNames>Coomaraswamy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>jTBJvj4ERfN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FC1B7AD-5C52-401B-B48E-0281C79D0079</gtr:id><gtr:title>Pathogenesis of the tauopathies.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>pm_13947_27_21785996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A7BD77D-D796-41CD-A8F5-EE6DB7E2874F</gtr:id><gtr:title>Distinct Spacing Between Anionic Groups: An Essential Chemical Determinant for Achieving Thiophene-Based Ligands to Distinguish ?-Amyloid or Tau Polymorphic Aggregates.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb7a730cbcfccb7946b6afd7833cc0fa"><gtr:id>cb7a730cbcfccb7946b6afd7833cc0fa</gtr:id><gtr:otherNames>Klingstedt T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>56cf114b9fb4f0.51058278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A3A3DEF-6270-42DC-8307-066D55996E74</gtr:id><gtr:title>Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54cbeb0a12b195b78bcf0572ae0cfe39"><gtr:id>54cbeb0a12b195b78bcf0572ae0cfe39</gtr:id><gtr:otherNames>Virdee K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>B921A0C2732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B1A0E99-1F29-4E08-A1F2-9BC980BDC86A</gtr:id><gtr:title>Piericidin A aggravates Tau pathology in P301S transgenic mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94b361db61ec8074f59f784a634bcec2"><gtr:id>94b361db61ec8074f59f784a634bcec2</gtr:id><gtr:otherNames>H?llerhage M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56cf12bf6b0f89.76372093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>981C0365-D537-43B2-9A9E-9A42FD6FD2F1</gtr:id><gtr:title>Sequence Determinants for Amyloid Fibrillogenesis of Human alpha-Synuclein.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63d933ac4d7cc10c11a493876994bb7d"><gtr:id>63d933ac4d7cc10c11a493876994bb7d</gtr:id><gtr:otherNames>Zibaee S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>28322555850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A06B224-0AA5-48E7-A6EA-C0D63A6DD658</gtr:id><gtr:title>Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568d4c05c5540e8104cf9ff299119e4d"><gtr:id>568d4c05c5540e8104cf9ff299119e4d</gtr:id><gtr:otherNames>Schaeffer V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13947_27_22689910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A5250E3-5A8E-431E-9230-FE0755011FA3</gtr:id><gtr:title>Oskar Fischer and the study of dementia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13947_17_18952676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4439EF-0868-458C-8A1A-423ED77F1A02</gtr:id><gtr:title>Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/307197eebdceffdead8d3232164e67c0"><gtr:id>307197eebdceffdead8d3232164e67c0</gtr:id><gtr:otherNames>Ishii A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>D87CF6D9968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDED246B-1939-420F-8C20-9583EE8CBBC2</gtr:id><gtr:title>Tau pathology and neurodegeneration.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9a459db5eb95e716cced7a352cee42f"><gtr:id>f9a459db5eb95e716cced7a352cee42f</gtr:id><gtr:otherNames>Spillantini MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_13947_27_23684085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86142719-3992-47FF-B5E2-6B0467BF6492</gtr:id><gtr:title>100 years of Lewy pathology.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_13947_27_23183883</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C2E10B-3DE5-44A6-ABE4-B18A263BCDEE</gtr:id><gtr:title>Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6616999c2cbf7228fb59c9ead8bbaa54"><gtr:id>6616999c2cbf7228fb59c9ead8bbaa54</gtr:id><gtr:otherNames>Broersen K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>602DB793C94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B9B4292-8F2A-422B-83DA-86CA4D45DF7D</gtr:id><gtr:title>Parkinson's Disease and Movement Disorders</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19333ce99e4b08f70f191bdc1fb98f08"><gtr:id>19333ce99e4b08f70f191bdc1fb98f08</gtr:id><gtr:otherNames>Spillantini MG, Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>mE4A96DXFcR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46F27E69-8960-46C3-B944-F19E114FBD16</gtr:id><gtr:title>Co-expression of truncated and full-length tau induces severe neurotoxicity.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db0dd8311c55f6ae2be27aedcd9d2100"><gtr:id>db0dd8311c55f6ae2be27aedcd9d2100</gtr:id><gtr:otherNames>Ozcelik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>58b5a404ac1f82.38515091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9316AE7F-BEB2-4793-9AA0-3E9F6276DEF1</gtr:id><gtr:title>Circadian clocks and neurodegenerative diseases: time to aggregate?</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90e68a4d89269ee0c75f69d1f2a908db"><gtr:id>90e68a4d89269ee0c75f69d1f2a908db</gtr:id><gtr:otherNames>Hastings MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>pm_13947_27_23797088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E0D3079-C9B8-4FE2-B8FF-E42C70405059</gtr:id><gtr:title>A role for FKBP52 in Tau protein function.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f10bb5f7b5796ea1ab9ac026bb86e4e"><gtr:id>7f10bb5f7b5796ea1ab9ac026bb86e4e</gtr:id><gtr:otherNames>Chambraud B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doxvqNd2soG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13AA916F-7D1C-49FA-88D8-1404E01A2FC9</gtr:id><gtr:title>Like prions: the propagation of aggregated tau and a-synuclein in neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58b5a46e37b026.93640242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AC82902-9911-46D6-9446-53A43B1DA22F</gtr:id><gtr:title>Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a495ed7fd32683dfa3c3a7f32c282b88"><gtr:id>a495ed7fd32683dfa3c3a7f32c282b88</gtr:id><gtr:otherNames>Bull ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13947_27_22496848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1644731-E2D8-40BB-B464-E64CC1B5C147</gtr:id><gtr:title>&amp;quot;Prion-like&amp;quot; templated misfolding in tauopathies.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>pm_13947_27_23587140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D8C12BA-9A5C-4F17-94A8-D6026059209A</gtr:id><gtr:title>Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cbd1eaaa78788ab9528c9e92a5e3f6f"><gtr:id>2cbd1eaaa78788ab9528c9e92a5e3f6f</gtr:id><gtr:otherNames>Mazzaro N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56d9808d4c3976.90423239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97FF2050-85A6-40CC-B668-991BB1269DF7</gtr:id><gtr:title>A Brief History of Tau.</gtr:title><gtr:parentPublicationTitle>Clinical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-9147</gtr:issn><gtr:outcomeId>56cef65e79df92.65614738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9B9922F-F2EC-450A-A02D-74605F2AA197</gtr:id><gtr:title>Synuclein proteins of the pufferfish Fugu rubripes: sequences and functional characterization.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f180a15663e642d6e2c71c1a59a300b"><gtr:id>8f180a15663e642d6e2c71c1a59a300b</gtr:id><gtr:otherNames>Yoshida H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>9E730D03750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CBC804F-A1A0-4BA9-AFAB-6530508E7A4E</gtr:id><gtr:title>The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c57fe98a7077ec4da99908912e27085"><gtr:id>3c57fe98a7077ec4da99908912e27085</gtr:id><gtr:otherNames>Spina S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>917356A6EC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>384BBEED-61B8-4260-852E-9945F6DB02AD</gtr:id><gtr:title>[Induction and spreading of tau pathology in a mouse model of Alzheimer's disease].</gtr:title><gtr:parentPublicationTitle>Medecine sciences : M/S</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0767-0974</gtr:issn><gtr:outcomeId>pm_13947_27_20188034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5822C34-5829-4253-A663-5E4D77A1BF78</gtr:id><gtr:title>The structure of cross-? tapes and tubes formed by an octapeptide, aS?1.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06999783b248e7a1785d9f48fcdef4e2"><gtr:id>06999783b248e7a1785d9f48fcdef4e2</gtr:id><gtr:otherNames>Morris KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>pm_13947_27_23307646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA104FF3-6906-4EBE-9CBB-0CEA2B253997</gtr:id><gtr:title>The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb7a730cbcfccb7946b6afd7833cc0fa"><gtr:id>cb7a730cbcfccb7946b6afd7833cc0fa</gtr:id><gtr:otherNames>Klingstedt T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>pm_13947_27_23780508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33B09E87-6AF9-4EE3-B011-4B5ADCF0041D</gtr:id><gtr:title>Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5c5431d1c8749df431cb44dc8c46368"><gtr:id>d5c5431d1c8749df431cb44dc8c46368</gtr:id><gtr:otherNames>Mellone M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>doi_13947_33_12_2013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D66CF0BB-2081-45E3-8637-CBD04A53998E</gtr:id><gtr:title>Frontotemporal lobar degeneration through loss of progranulin function.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13947_17_17071919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB9C213F-0455-4E86-BCD8-F9748A756DF6</gtr:id><gtr:title>Brain homogenates from human tauopathies induce tau inclusions in mouse brain.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13947_27_23690619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06FAE7D9-5C78-433E-A058-FC4EABEDD4F1</gtr:id><gtr:title>SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d81c53157ae8e9a32a6f64c9afc83958"><gtr:id>d81c53157ae8e9a32a6f64c9afc83958</gtr:id><gtr:otherNames>Garcia-Reitb?ck P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>SyBHo3oRLPN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>217D587D-F5CE-4EA2-9BD3-0793B47B95FB</gtr:id><gtr:title>SYMPOSIUM: Tau Protein and Neurodegeneration</gtr:title><gtr:parentPublicationTitle>Brain Pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ea3e129b0f6e620740ca66a5e93d5ff"><gtr:id>2ea3e129b0f6e620740ca66a5e93d5ff</gtr:id><gtr:otherNames>Ghetti B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>mD2STzkYyYf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8208D84-5D3F-4E7F-AE08-6A01C872D102</gtr:id><gtr:title>Phosphorylation of microtubule-associated protein tau by AMPK-related kinases.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f180a15663e642d6e2c71c1a59a300b"><gtr:id>8f180a15663e642d6e2c71c1a59a300b</gtr:id><gtr:otherNames>Yoshida H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_13947_27_21985311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1152C05A-E045-46BC-A235-F5A1840FE79E</gtr:id><gtr:title>Transmission and spreading of tauopathy in transgenic mouse brain.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>B581A0BDCC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14C9BE85-F6FE-4600-85A8-3E2DA62E2075</gtr:id><gtr:title>Tau protein, the paired helical filament and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e863ed595995a076772770d26fdb1ca"><gtr:id>5e863ed595995a076772770d26fdb1ca</gtr:id><gtr:otherNames>Goedert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_13947_17_16914859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79E014DD-B5A0-4471-AC07-CBA68ED5ECE9</gtr:id><gtr:title>Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09671622498def6bbe461d8198ef4e5d"><gtr:id>09671622498def6bbe461d8198ef4e5d</gtr:id><gtr:otherNames>Tofaris GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>4CAA8A6509B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C15118F-10C5-4140-9281-ED28B8974373</gtr:id><gtr:title>The Transcellular Propagation and Intracellular Trafficking of a-Synuclein.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09671622498def6bbe461d8198ef4e5d"><gtr:id>09671622498def6bbe461d8198ef4e5d</gtr:id><gtr:otherNames>Tofaris GK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>58b5a50834ff43.34906597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89E59728-64D5-4AA8-9023-3D565B004BF7</gtr:id><gtr:title>What is the evidence that tau pathology spreads through prion-like propagation?</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24f1e5389a337c6fb43b3be1a7303d08"><gtr:id>24f1e5389a337c6fb43b3be1a7303d08</gtr:id><gtr:otherNames>Mudher A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5a82dec8c86953.44215729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>489CD3F2-EF3A-4995-AC7D-4EFDBE8A1049</gtr:id><gtr:title>Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fddea35361295ee03f83b96df8cf9150"><gtr:id>fddea35361295ee03f83b96df8cf9150</gtr:id><gtr:otherNames>Clavaguera F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_13947_27_24362441</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105184291</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>